| abstract |
The present invention is an insulin derivative comprising a reactive group covalently bound to an insulin molecule and a blood component, preferably the insulin molecule is a human natural insulin molecule, and the reactive group comprises Gly A1, Phe B1, and The present invention relates to a derivative that is bonded to an amino acid of an insulin molecule at a position selected from positions of Lys B29. |